MYFORTIC 180MG TABLET
| Product Name | Myfortic 180mg Tablet |
| Composition | Mycophenolic Acid 180mg |
| Form | Tablet |
| Category | Immunosuppressant |
| Indications | Prevention of organ rejection (Kidney transplant) |
| Dosage | As prescribed by transplant specialist |
| Packaging | Strip or bottle pack |
| Storage | Store below 25Β°C in a dry place |
MYFORTIC 180MG TABLET
Myfortic 180mg Tablet is an immunosuppressant medicine used to prevent organ rejection in patients who have undergone kidney transplantation. It contains Mycophenolic Acid, which works by suppressing the immune system to prevent it from attacking the transplanted organ. Myfortic is usually prescribed in combination with other immunosuppressive medicines such as corticosteroids and calcineurin inhibitors.
Myfortic 180mg Tablet helps reduce the risk of acute rejection episodes by inhibiting the growth of immune cells responsible for attacking the transplanted organ. It plays a crucial role in long-term transplant success and helps maintain proper organ function. Regular monitoring is necessary during treatment to manage potential side effects and ensure optimal dosing.
Myfortic 180mg Tablet should be taken exactly as prescribed by a transplant specialist. Consistent use is essential for preventing rejection and maintaining transplant health. Patients must follow medical advice carefully and attend regular checkups to ensure safe and effective therapy.
Product Features
- Contains Mycophenolic Acid 180mg
- Prevents organ rejection after kidney transplant
- Used in combination immunosuppressive therapy
- Helps protect transplanted organ function
- Requires regular medical monitoring
How It Helps
- Suppresses immune system response
- Prevents rejection of transplanted organ
- Supports long-term transplant success
- Maintains proper organ function

Reviews
There are no reviews yet.